the Sixth All-hands meeting of INSIST was again held online, on May 27-28 2021. For the  agenda, read on. 

We had two invited speakers,  who held excellent talks.

Marco Viceconti- the ISW project and the regulatory landscape that are emerging in Europe, and that we need to overcome.

Frank Gijsen- mechanics and imaging of intracranial thrombi

 

The Fourth All-hands meeting of INSIST was planned on April 2-3, 2020 in Moscow.

However, due to the worldwide coronavirus crisis, the meeting unfortunately had to be cancelled. But thanks to the excellent organization of our Russian partners, we had a first online virtual meeting, with all partners present!

virtual meeting

For the agenda, click below. 

 

the Fifth All-hands meeting of INSIST washeld in virtual Galway, 28-29 October, For the  agenda, click below. 

We had two invited speakers, Prof. Mayank Goyal (interventional neuroradiologist, University Calgary) and Dr. Karen Doyle (Discipline of Physiology, National University of Ireland Galway) who held excellent talks. Please click on their names to watch their presentation.

 

The Third All-hands meeting of INSIST was held November 11th-12th 2019 in Rotterdam, The Netherlands, at the Erasmus Medical Center.

EMC 

After a short introduction, all partners gave presentations summarizing the progress in the past year of the project, followed by discussions, according to the program.

On the second day we also had another Focus group meeting, this time focusing on the connections with INSIST.

The seconds All-hands meeting of INSIST was held April 3rd-4th 2019 in Milano, Italy.

After a short introduction, all partners give presentations summarizing the progress in the past year of the project. But first the meeting started with the launch of the first in silico clinical trial by our project coordinator Charles Majoie.

1st in silico trial 400x300

Matthew Gounis has just given an excellent lecture as Key-note speaker.

The first All-hands meeting of INSIST was September 24th-25th 2018 in Oxford, UK.

After a short introduction, all partners gave a 40-60 minutes presentation summarizing the progress in the past year of the project. A very rough model of the first in silico clinical trial model was presented as well as all separate data that whould be included and needed to be taken into account. Further discussion ensued between the different partners to clarify what is needed to improve on the model.